Ensho Therapeutics Form D (2026)
Ensho Therapeutics reported $7,281,948 raised in an SEC Form D filed on 2026-10-15.
- Company
- Ensho Therapeutics
- Round type
- Form D
- Date
- 2026-10-15
- Amount
- $7.28M
- Industry
- Biotechnology
- Location
- New Jersey
Summary
The SEC Form D for Ensho Therapeutics, filed on 2026-10-15, reports $7,281,948 raised. It was listed in the Raise Track Update of 2026-10-16. Filing: https://www.sec.gov/Archives/edgar/data/2032849/000203284926000002/0002032849-26-000002-index.htm
This page is not indexed by search engines yet because the filing is its only source.
Investors
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2032849/000203284926000002/0002032849-26-000002-index.htm
Type: sec filing. Accessed 2026-10-16.
SEC Form D for Ensho Therapeutics, Inc. EDGAR filing date 2026-10-15. Signed 2026-10-15. First sale 2026-10-02. Total amount sold $7,281,948 of an offering amount of $15,604,179. 7 investors already invested. Issuer address city is Woodcliff Lake, New Jersey. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2024. The form does not name the purchasers or a round type. Street addresses are not published. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-16/
Type: other verified public source. Accessed 2026-10-16.
Raise Track Update for 2026-10-16, Section 3. Lists Ensho Therapeutics, state NEW JERSEY, industry Biotechnology, amount raised $7,281,948.